Faslodex Registry: Fulvestrant in Current Clinical Practice

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2008

Study Completion Date

December 31, 2009

Conditions
Metastatic Breast Cancer
Trial Locations (12)

Unknown

Research Site, Antwerp

Research Site, Bruges

Research Site, Brussels

Research Site, Ghent

Research Site, Kortrijk

Research Site, Leuven

Research Site, Liège

Research Site, Namur

Research Site, Ostend

Research Site, Roeselare

Research Site, Turnhout

Research Site, Wilrijk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY